Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. REGEN-COV antibody combo cuts COVID-19 hospitalisations and deaths

    Publicly released: Thu 30 Sep 2021 at 0700 AEST, 1000 NZDT

    NEJM

    A US trial of REGEN-COV, a combination of the COVID-19 antibodies casirivimab and imdevimab, in 2,696 COVID-19 patients found the antibody treatment cut the risk of death ... The treatment also cut the Read more about REGEN-COV antibody combo cuts COVID-19 hospitalisations and deaths

    InternationalRegeneron Pharmaceuticals, USA

  2. One pandemic in the UK, but diverging experiences

    Publicly released: Thu 30 Sep 2021 at 0400 AEST, 0700 NZDT

    PLOS ONE

    The Covid-19 pandemic has had varying impacts on people’s income, time use and well-being, depending on gender and ethnicity. ... Differential effects of UK COVID-19 lockdowns tracked across social Read more about One pandemic in the UK, but diverging experiences

    InternationalUniversity of Oxford (UK), Hong Kong University of Science and Technology (Guangzhou, China)

  3. US vaccine rollouts by age prevent twice as many white deaths as Black deaths

    Publicly released: Thu 30 Sep 2021 at 0400 AEST, 0700 NZDT

    Science Advances

    This study analyzed how hypothetical vaccination plans could affect COVID-19 mortality and equity in California and Minnesota, 2 demographically divergent states. ... risk of exposure to SARS-CoV-2 is Read more about US vaccine rollouts by age prevent twice as many white deaths as Black deaths

    InternationalUniversity of Minnesota, Stanford University, Harvard University, University of California San Francisco, University of California, Berkeley (USA), and French Institute for Demographic Studies, France

  4. Aussie GPs have concerns about keeping safe from COVID-19

    Publicly released: Thu 30 Sep 2021 at 0001 AEST, 0301 NZDT

    Australian Journal of Primary Health

    GPs said they needed more information, education and resources on vaccines to help them manage their role in the COVID-19 pandemic, which they saw as being to educate the public, ... correct Read more about Aussie GPs have concerns about keeping safe from COVID-19

    Australia; NSW; QLDThe University of Sydney | The University of Queensland

  5. Melbourne-made COVID-19 treatment could future-proof Australia

    Publicly released: Wed 29 Sep 2021 at 1530 AEST, 1830 NZDT

    Cell Reports

    Scientists found antibodies that blocked the SARS-CoV-2 virus from entering cells in preclinical models. ... Antibodies from recovered COVID-19 patients and CSL’s proprietary antibody library were used Read more about Melbourne-made COVID-19 treatment could future-proof Australia

    Australia; VICWEHI

  6. Drugs that make COVID-19 even a little less contagious could have a big impact on the pandemic

    Publicly released: Wed 29 Sep 2021 at 0901 AEST, 1201 NZDT

    Journal of the Royal Society Interface

    The authors modelled what features of potential drug treatments would have the greatest influence on stopping the COVID-19 pandemic and found that starting treatment early is the key. ... A modelling Read more about Drugs that make COVID-19 even a little less contagious could have a big impact on the pandemic

    InternationalUniversité de Picardie Jules Verne, France

  7. Why do fewer young adults follow the rules on COVID-19 prevention?

    Publicly released: Wed 29 Sep 2021 at 0901 AEST, 1201 NZDT

    Royal Society Open Science

    Against expectations, the age variation wasn’t explained by differences in the objective risk of Covid-19 complications, or attitudes toward risk. ... The authors speculate that being better with Read more about Why do fewer young adults follow the rules on COVID-19 prevention?

    InternationalUniversity of Essex, UK; University of Edinburgh, UK

  8. Could artificial intelligence predict the next pandemic?

    Publicly released: Wed 29 Sep 2021 at 0400 AEST, 0700 NZDT

    PLOS Biology

    AI may predict the next virus to jump from animals to humans Most emerging infectious diseases of humans (like COVID-19) are zoonotic – caused by viruses originating from other animal species. Read more about Could artificial intelligence predict the next pandemic?

    InternationalUniversity of Glasgow, UK

  9. EXPERT REACTION: Home tests for COVID-19 approved by TGA

    Publicly released: Tue 28 Sep 2021 at 1235 AEST, 1535 NZDT

    Australians will be able to test themselves for COVID-19 at home after the Therapeutic Goods Administration (TGA) approved the use of rapid antigen tests. ... Health Minister Greg Hunt announced today the Read more about EXPERT REACTION: Home tests for COVID-19 approved by TGA

    Australia; NSW; VIC; QLD; SA; WAThe University of Queensland | Griffith University ...

  10. BACKGROUND BRIEFING: How are we treating COVID-19 in Australia?

    Publicly released: Tue 28 Sep 2021 at 1000 AEST, 1300 NZDT

    our cases rise?Speakers:Professor Julian Elliott is Executive Director of the National COVID-19 Clinical Evidence Taskforce and a Senior Research Fellow at Cochrane Australia, Monash ... a clinician Read more about BACKGROUND BRIEFING: How are we treating COVID-19 in Australia?

    Australia; NSW; VICAustralian Science Media Centre

  11. Border workers should be tested every 4 days to beat delta, modelling suggests

    Publicly released: Tue 28 Sep 2021 at 0901 AEST, 1201 NZDT

    Royal Society Open Science

    New Zealand and Australia have followed a COVID-19 elimination strategy, focusing on strict border controls to keep the virus out of the community. ... These workers are at high risk of exposure to the Read more about Border workers should be tested every 4 days to beat delta, modelling suggests

    New ZealandUniversity of Canterbury | University of Auckland ...

  12. Smoking increases your chance of severe COVID-19

    Publicly released: Tue 28 Sep 2021 at 0830 AEST, 1130 NZDT

    Thorax

    the severity of COVID-19 and the risk of dying from the infection, finds a large UK Biobank study published online in the respiratory journal Thorax. ... Notes for editorsResearch: Smoking and COVID-19 Read more about Smoking increases your chance of severe COVID-19

    InternationalUniversity of Oxford, UK

  13. EXPERT REACTION: Trust in scientists drives public buy-in to pandemic restrictions

    Publicly released: Tue 28 Sep 2021 at 0500 AEST, 0800 NZDT

    Proceedings of the National Academy of Sciences

    Researchers examine trust in scientists during the COVID-19 pandemic. The COVID-19 pandemic has strained public trust not only in governments but also in scientists, affecting attitudes toward policy Read more about EXPERT REACTION: Trust in scientists drives public buy-in to pandemic restrictions

    Australia; New Zealand; InternationalEcole des Hautes Etudes Commerciales, France; Ecole Normale Supérieure, France; Sciences Po, France; Harvard University, US

  14. Targeting a key protein to fight inflammatory disease

    Publicly released: Tue 28 Sep 2021 at 0200 AEST, 0500 NZDT

    Molecular Cell

    When activated inappropriately, the system drives inflammatory diseases such as sepsis, COVID-19, stroke, heart attacks, cancers and brain illnesses,” Professor Woodruff said. ... Our study investigated Read more about Targeting a key protein to fight inflammatory disease

    Australia; QLDThe University of Queensland

  15. Two in three hesitant people shift to say 'yes' to vaccine

    Publicly released: Sat 25 Sep 2021 at 0100 AEST, 0300 NZST

    JAMA Network Open

    Covid-19 vaccine hesitancy waned between late 2020 and early 2021, in a US study of more than 3,000 people. ... Association of Initial COVID-19 Vaccine Hesitancy With Subsequent VaccinationWhat The Study Read more about Two in three hesitant people shift to say 'yes' to vaccine

    InternationalEmory University, US; Georgia State University, US

  16. 1 in 7 avoid ED in pandemic times

    Publicly released: Fri 24 Sep 2021 at 1130 AEST, 1330 NZST

    JMIR Human Factors

    Self-management, and the avoidance of any professional care, was more common in older individuals and those with poor or very poor general health – groups at heightened risk of COVID-19 ... The study, Read more about 1 in 7 avoid ED in pandemic times

    Australia; SAFlinders University

  17. EXPERT REACTION: Antibody cocktail recommended for high-risk COVID-19 patients

    Publicly released: Fri 24 Sep 2021 at 0901 AEST, 1101 NZST

    THE BMJ

    Casirivimab and imdevimab are monoclonal antibodies that when used together bind to the SARS-CoV-2 spike protein, neutralising the virus’s ability to infect cells. ... the management of covid-19 and Read more about EXPERT REACTION: Antibody cocktail recommended for high-risk COVID-19 patients

    InternationalMcMaster University and Toronto University (Canada), University Hospitals of Geneva (Switzerland), MAGIC Evidence Ecosystem Foundation, World Health Organization.

  18. Drug repurposing is no panacea in race to treat COVID-19

    Publicly released: Thu 23 Sep 2021 at 0826 AEST, 1026 NZST

    Science Translational Medicine

    Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and  there are inherent dangers and pitfalls with translating drugs such as chloroquine, ... Professor Read more about Drug repurposing is no panacea in race to treat COVID-19

    Australia; VIC; QLDMonash University | The University of Melbourne | Griffith University ...

  19. Moderna vaccine reports 98.2% efficacy against severe COVID-19

    Publicly released: Thu 23 Sep 2021 at 0700 AEST, 0900 NZST

    New England Journal of Medicine

    214 people who received the vaccine had an asymptomatic infection compared to 498 in the placebo group, 55 developed COVID-19 illness compared to 744 in the placebo group and two ... vaccinated people had Read more about Moderna vaccine reports 98.2% efficacy against severe COVID-19

    InternationalBaylor College of Medicine, USA

  20. Contact tracing apps could help target vaccines to future super-spreaders

    Publicly released: Thu 23 Sep 2021 at 0400 AEST, 0600 NZST

    PLOS ONE

    The COVID-19 pandemic has raised questions about how to best allocate limited supplies of vaccines for the greatest benefit against a disease. ... The researchers found improvements even for simulations Read more about Contact tracing apps could help target vaccines to future super-spreaders

    InternationalPerimeter Institute for Theoretical Physics, Canada

Show Results

  1. 10
  2. 20
  3. 50